According to a randomized controlled trial, dronedarone is envisioned as a safer alternative to amiodarone in patients with atrial fibrillation. Medscape Medical News
A new study finds that many US Food and Drug Administration drug risk communications have a delayed effect, unintended consequences, or no effect. Medscape Medical News
Medscape interviews Dr. Kalantar-Zadeh on the effects of vitamin D receptor activators (VDRAs) on bone and mineral metabolism and survival in ESRD patients with secondary hyperparathyroidism. Medscape Nephrology
The analysis also looked at the effect of PPIs and found that they were associated with an increased risk of events only in high-risk patients. Heartwire